GPP
FMTX

Great Point Partners’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Great Point Partners’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-236,400
Closed -$8.25M – 40
2020
Q4 		$8.25M Buy
+236,400
New +$10.3M 1.34% 25

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Great Point Partners's FMTX Position: Q1 2021 in Review

Great Point Partners sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q1 2021, closing a stake of 236,400 shares — an estimated $8.25M sold.

Great Point Partners first reported a position in FMTX in Q4 2020 and held it in 1 quarter. The position peaked at $8.25M in Q4 2020. 87 funds tracked by Wall St. Rank hold FMTX as of Q1 2021.

  • Great Point Partners reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Great Point Partners sold 236,400 Forma Therapeutics Holdings, Inc. Common Stock shares in Q1 2021, an estimated $8.25M.
  • Great Point Partners first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Great Point Partners's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $8.25M in Q4 2020.
  • 87 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q1 2021.

Based on Great Point Partners's 13F filing for Q1 2021, filed 17 May 2021.